A triple blind, placebo controlled, randomised controlled trial of betahistine dihydrochloride in the treatment of primary tinnitus.

导出原文传递

翻译打印收藏纠错

作者： Gustavo Leão,Castilho ^[1] ; Norimar Hernanes,Dias ^[1] ; Regina Helena Garcia,Martins ^[1]

作者单位： Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery Department, Universidade Estadual Paulista Julio de Mesquita Filho, Botucatu Medical School, São Paulo, Brazil. ^[1]

关键词 betahistine dihydrochloride clinical trial tinnitus treatment

主题词成年人(Adult);男(雄)性(Male);人类(Humans);女(雌)性(Female);中年人(Middle Aged);倍他司汀(Betahistine);耳鸣(Tinnitus);巴西(Brazil);助听器(Hearing Aids);治疗结果(Treatment Outcome)

DOI 10.1111/coa.13999

PMID 36320174

发布时间 2023-01-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical otolaryngology

2023年48卷1期

50-57页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A triple blind, placebo controlled, randomised controlled trial of betahistine dihydrochloride in the treatment of primary tinnitus.

Clinical otolaryngology

相似文献

Clinical otolaryngology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A triple blind, placebo controlled, randomised controlled trial of betahistine dihydrochloride in the treatment of primary tinnitus.

Clinical otolaryngology

相似文献

Clinical otolaryngology

相关期刊

检索历史清除